without surgery for dogs with high grade mast cell tumors with regional lymph node metastases. Vet Cancer Soc Newsl 20:6–7.
184 Elmslie, R.E., S.W. Dow, and T.A. Potter. 1994. Genetic immunotherapy of canine oral melanoma. Vet Cancer Soc Proc 14:111.
185 Elmslie, R.E., P. Glawe, and S.W. Dow. 2008. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. J Vet Intern Med 22:1373–1379.
186 Elmslie, R.E., T.A. Potter, and S.W. Dow. 1995. Direct DNA injection for the treatment of malignant melanoma. Vet Cancer Soc Proc 15:52.
187 Elston, L.B., F.A. Sueiro, J.N. Cavalcanti, et al. 2009. The importance of the mitotic index as a prognostic factor for survival of canine cutaneous mast cell tumors: A validation study. Vet Pathol 46:362–364, author reply 364–365.
188 Emms, S.G. 2005. Anal sac tumours of the dog and their response to cytoreductive surgery and chemotherapy. Aust Vet J 83:340–343.
189 Epple, L.M., L.T. Bemis, R.P. Cavanaugh, et al. 2013. Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour‐derived chaperone‐rich cell lysate (Crcl) vaccine. Int J Hyperthermia 29:390–398.
190 Esplin, D.G. 2008. Survival of dogs following surgical excision of histologically well‐differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity. Vet Pathol 45:889–896.
191 Evans, S.M. 1987. Canine haemangiopericytoma: A retrospective analysis of response to surgery and orthovoltage radiation. Vet Radiol 28:13.
192 Evans, S.M., M. Goldschmidt, L.J. Mckee, et al. 1989. Prognostic factors and survival after radiotherapy for intranasal neoplasms in dogs: 70 cases (1974–1985). J Am Vet Med Assoc 194:1460–1463.
193 Evans, S.M. and D.E. Thrall. 1983. Postoperative orthovoltage radiation therapy of parotid salivary gland adenocarcinoma in three dogs. J Am Vet Med Assoc 182:993–994.
194 Fahey, C.E., R.J. Milner, K. Barabas, et al. 2011. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003–2009). J Am Vet Med Assoc 239:209–215.
195 Fan, T.M. 2007. The role of bisphosphonates in the management of patients that have cancer. Vet Clin North Am Small Anim Pract 37:1091–1110; vi.
196 Fan, T.M. 2009. Intravenous aminobisphosphonates for managing complications of malignant osteolysis in companion animals. Top Companion Anim Med 24:151–156.
197 Fan, T.M., S.C. Charney, L.P. De Lorimier, et al. 2009. Double‐blind placebo‐controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain. J Vet Intern Med 23:152–160.
198 Fan, T.M., L.P. De Lorimier, S.C. Charney, et al. 2005. Evaluation of intravenous pamidronate administration in 33 cancer‐bearing dogs with primary or secondary bone involvement. J Vet Intern Med 19:74–80.
199 Fan, T.M., L.P. De Lorimier, L.D. Garrett, et al. 2008. The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis. J Vet Intern Med 22:380–387.
200 Fan, T.M., L.P. De Lorimier, K. O’dell‐Anderson, et al. 2007. Single‐agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain. J Vet Intern Med 21:431–439.
201 Fan, T.M., B.E. Kitchell, R.S. Dhaliwal, et al. 2002. Haematological toxicity and therapeutic efficacy of lomustine in 20 tumor‐bearing cats: Critical assessment of a practical dosing regimen. J Am Anim Hosp Assoc 38:357–363.
202 Farese, J.P., J. Kirpensteijn, M. Kik, et al. 2009. Biologic behavior and clinical outcome of 25 dogs with canine appendicular chondrosarcoma treated by amputation: A Veterinary Society of Surgical Oncology retrospective study. Vet Surg 38:914–919.
203 Farese, J.P., R. Milner, M.S. Thompson, et al. 2004. Stereotactic radiosurgery for treatment of osteosarcomas involving the distal portions of the limbs in dogs. J Am Vet Med Assoc 225:1567–1572, 1548.
204 Farrelly, J., D.L. Denman, A.E. Hohenhaus, et al. 2004. Hypofractionated radiation therapy of oral melanoma in five cats. Vet Radiol Ultrasound 45:91–93.
205 Feldman, E.C. and R.W. Nelson. 2004. Beta‐cell neoplasia: Insulinomas. In Canine and Feline Endocrinology and Reproduction, 3rd edition. Feldman, E.C. and R.W. Nelson, editors. St. Louis: Saunders.
206 Fineman, L.S., T.A. Hamilton, A. De Gortari, et al. 1998. Cisplatin chemotherapy for treatment of thyroid carcinoma in dogs: 13 cases. J Am Anim Hosp Assoc 34:109–112.
207 Finocchiaro, L.M. and G.C. Glikin. 2012. Cytokine‐enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow‐up. Cancer Gene Ther 19:852–861.
208 Flanders, J.A. 1999. Surgical options for the treatment of hyperthyroidism in the cat. J Feline Med Surg 1:127–134.
209 Flanders, J.A., H.J. Harvey, and H.N. Erb. 1987. Feline thyroidectomy. A comparison of postoperative hypocalcemia associated with three different surgical techniques. Vet Surg 16:362–366.
210 Flory, A.B., K.M. Rassnick, R. Al‐Sarraf, et al. 2008. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs. J Vet Intern Med 22:164–171.
211 Flory, A.B., K.M. Rassnick, H.N. Erb, et al. 2011. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000–2007). J Am Vet Med Assoc 238:501–506.
212 Fonda, D., M. Gualtieri, and E. Scanziani. 1989. Gastric carcinoma in the dog: A clinicopathological study of 11 cases. J Small Anim Pract 30:353–360.
213 Forrest, L.J., R. Chun, W.M. Adams, et al. 2000. Postoperative radiotherapy for canine soft tissue sarcoma. J Vet Intern Med 14:578–582.
214 Forster‐Van Hijfte, M.A., C.F. Curtis, and R.N. White. 1997. Resolution of exfoliative dermatitis and Malassezia pachydermatis overgrowth in a cat after surgical thymoma resection. J Small Anim Pract 38:451–454.
215 Fowler, E.H., G.P. Wilson, and A. Koestner. 1974. Biologic behavior of canine mammary neoplasms based on a histogenetic classification. Vet Pathol 11:212–229.
216 Frazier, S.A., S.M. Johns, J. Ortega, et al. 2012. Outcome in dogs with surgically resected oral fibrosarcoma (1997–2008). Vet Comp Oncol 10:33–43.
217 Freeman, K.P., K.A. Hahn, F.D. Harris, et al. 2003. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum‐based chemotherapy (1987–1997). J Vet Intern Med 17:96–101.
218 Frenais, R., D. Rosenberg, S. Burgaud, et al. 2009. Clinical efficacy and safety of a once‐daily formulation of carbimazole in cats with hyperthyroidism. J Small Anim Pract 50:510–515.
219 Frimberger, A.E., A.S. Moore, S.M. Larue, et al. 1997. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989–1993). J Am Anim Hosp Assoc 33:320–324.
220 Fujiwara, A., T. Kobayashi, Y. Kazato, et al. 2013. Efficacy of hypofractionated radiotherapy for nasal tumours in 38 dogs (2005–2008). J Small Anim Pract 54:80–86.
221 Fukui, S., Y. Endo, K. Hirayama, et al. 2015. Identification and preservation of the parathyroid gland during total thyroidectomy in dogs with bilateral thyroid carcinoma: A report of six cases. J Vet Med Sci 77:747–751.
222 Fulcher, R.P., L.L. Ludwig, P.J. Bergman, et al. 2006. Evaluation of a two‐centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 228:210–215.
223 Gabai, V., F.M. Venanzi, E. Bagashova, et al. 2014. Pilot study of p62 DNA vaccine in dogs with mammary tumors. Oncotarget 5:12803–12810.
224 Gardner, H., J. Fidel, G. Haldorson, et al. 2015a. Canine oral fibrosarcomas: A retrospective analysis of 65 cases (1998‐2010). Vet Comp Oncol 13:40–47.
225 Gardner,